(Q42950348)

11 November 2017

title

The effects of acarbose treatment on intimal hyperplasia in a rat carotid endarterectomy model of diet-induced insulin resistance (English)

1 reference

11 November 2017

The Effects of Acarbose Treatment on Intimal Hyperplasia in a Rat Carotid Endarterectomy Model of Diet-Induced Insulin Resistance (English)

1 reference

https://api.crossref.org/works/10.1177/1538574410377019

14 June 2024

1 reference

1 reference

Shaoke Luo

2

1 reference

11 November 2017

John O. Nyalala

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20675317

14 June 2024

Danielle N. Campbell

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20675317

14 June 2024

Aliza T. Brown

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20675317

14 June 2024

Mohammed M. Moursi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20675317

14 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20675317

14 June 2024

publication date

30 July 2010

1 reference

full work available at URL

11 November 2017

http://journals.sagepub.com/doi/pdf/10.1177/1538574410377019

1 reference

https://api.crossref.org/works/10.1177/1538574410377019

Vascular and Endovascular Surgery

14 June 2024

published in

1 reference

11 November 2017

volume

44

1 reference

11 November 2017

issue

7

1 reference

11 November 2017

page(s)

560-567

1 reference

Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Who should benefit from the use of alpha-glucosidase inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Acarbose: oral anti-diabetes drug with additional cardiovascular benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Intimal hyperplasia following carotid endarterectomy in an insulin-resistant rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Pravastatin and clopidogrel combined inhibit intimal hyperplasia in a rat carotid endarterectomy model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Plasma homocysteine measurements after carotid artery manipulation and clamping in a rat CEA model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Cigarette smoke increases intimal hyperplasia and homocysteine in a rat carotid endarterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

The effects of Toradol on postoperative intimal hyperplasia in a rat carotid endarterectomy model: laboratory research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Effect of clopidogrel on platelet aggregation and intimal hyperplasia following carotid endarterectomy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Postprandial hyperglycaemia and vascular damage--the benefits of acarbose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Potential mechanisms promoting restenosis in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

An alpha-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

TAGE (toxic AGEs) theory in diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Treatment with acarbose may improve endothelial dysfunction in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574410377019

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1177/1538574410377019

Acarbose, an alpha-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1177/1538574410377019

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity

14 June 2024

21

19

S39

Ridray S.

1995

1 reference

https://api.crossref.org/works/10.1177/1538574410377019

Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1177/1538574410377019

14 June 2024

Identifiers

1 reference

11 November 2017

1 reference